Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Salmones Camanchaca

SNSE:SALMOCAM
Snowflake Description

Good value with proven track record.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
SALMOCAM
SNSE
CLP277B
Market Cap
  1. Home
  2. CL
  3. Food, Beverage & Tobacco
Company description

Salmones Camanchaca S.A. engages in the salmon farming business in Chile. The last earnings update was 34 days ago. More info.


Add to Portfolio Compare Print
  • Salmones Camanchaca has significant price volatility in the past 3 months.
SALMOCAM Share Price and Events
7 Day Returns
0%
SNSE:SALMOCAM
1.1%
CL Food
8.4%
CL Market
1 Year Returns
-34%
SNSE:SALMOCAM
-24.3%
CL Food
-34.1%
CL Market
SALMOCAM Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Salmones Camanchaca (SALMOCAM) 0% -27% -35.5% -34% - -
CL Food 1.1% -10.3% -14.7% -24.3% 5% 47.2%
CL Market 8.4% -16.6% -24.9% -34.1% -30.5% -26.8%
1 Year Return vs Industry and Market
  • SALMOCAM underperformed the Food industry which returned -24.3% over the past year.
  • SALMOCAM matched the Chile Market (-34.1%) over the past year.
Price Volatility
SALMOCAM
Industry
5yr Volatility vs Market

SALMOCAM Value

 Is Salmones Camanchaca undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Salmones Camanchaca to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Salmones Camanchaca.

SNSE:SALMOCAM Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 4 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 12.5%
Perpetual Growth Rate 10-Year CL Government Bond Rate 7.5%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for SNSE:SALMOCAM
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year CL Govt Bond Rate 7.5%
Equity Risk Premium S&P Global 6.3%
Food Unlevered Beta Simply Wall St/ S&P Global 0.56
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.565 (1 + (1- 26%) (31.31%))
0.796
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 7.47% + (0.8 * 6.33%)
12.53%

Discounted Cash Flow Calculation for SNSE:SALMOCAM using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Salmones Camanchaca is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

SNSE:SALMOCAM DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 12.53%)
2020 23.44 Analyst x2 20.83
2021 52.34 Analyst x2 41.33
2022 43.02 Analyst x2 30.19
2023 38.57 Est @ -10.36% 24.05
2024 36.63 Est @ -5.01% 20.30
2025 36.17 Est @ -1.26% 17.81
2026 36.66 Est @ 1.36% 16.04
2027 37.83 Est @ 3.19% 14.71
2028 39.52 Est @ 4.47% 13.66
2029 41.65 Est @ 5.37% 12.79
Present value of next 10 years cash flows $211.00
SNSE:SALMOCAM DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $41.65 × (1 + 7.47%) ÷ (12.53% – 7.47%)
$883.87
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $883.87 ÷ (1 + 12.53%)10
$271.36
SNSE:SALMOCAM Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $211.00 + $271.36
$482.36
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $482.36 / 66.00
$7.31
SNSE:SALMOCAM Discount to Share Price
Calculation Result
Exchange Rate USD/CLP
(Reporting currency to currency of SNSE:SALMOCAM)
864.09
Value per Share
(CLP)
= Value per Share in USD x Exchange Rate (USD/CLP)
= $7.31 x 864.09
CLP6315.24
Value per share (CLP) From above. CLP6,315.24
Current discount Discount to share price of CLP4,192.50
= -1 x (CLP4,192.50 - CLP6,315.24) / CLP6,315.24
33.6%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Salmones Camanchaca is available for.
Intrinsic value
34%
Share price is CLP4192.5 vs Future cash flow value of CLP6315.24
Current Discount Checks
For Salmones Camanchaca to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Salmones Camanchaca's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Salmones Camanchaca's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Salmones Camanchaca's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Salmones Camanchaca's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
SNSE:SALMOCAM PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $0.64
SNSE:SALMOCAM Share Price ** SNSE (2020-04-01) in CLP CLP4192.5
SNSE:SALMOCAM Share Price converted to USD reporting currency Exchange rate (CLP/ USD) 0.001 $4.85
Chile Food Industry PE Ratio Median Figure of 14 Publicly-Listed Food Companies 10.24x
Chile Market PE Ratio Median Figure of 130 Publicly-Listed Companies 10.71x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Salmones Camanchaca.

SNSE:SALMOCAM PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= SNSE:SALMOCAM Share Price ÷ EPS (both in USD)

= 4.85 ÷ 0.64

7.56x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Salmones Camanchaca is good value based on earnings compared to the CL Food industry average.
  • Salmones Camanchaca is good value based on earnings compared to the Chile market.
Price based on expected Growth
Does Salmones Camanchaca's expected growth come at a high price?
Raw Data
SNSE:SALMOCAM PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 7.56x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts
13.1%per year
South America Food Industry PEG Ratio Median Figure of 13 Publicly-Listed Food Companies 1.28x
Chile Market PEG Ratio Median Figure of 30 Publicly-Listed Companies 0.83x

*Line of best fit is calculated by linear regression .

SNSE:SALMOCAM PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 7.56x ÷ 13.1%

0.58x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Salmones Camanchaca is good value based on expected growth next year.
Price based on value of assets
What value do investors place on Salmones Camanchaca's assets?
Raw Data
SNSE:SALMOCAM PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $3.09
SNSE:SALMOCAM Share Price * SNSE (2020-04-01) in CLP CLP4192.5
SNSE:SALMOCAM Share Price converted to USD reporting currency Exchange rate (CLP/ USD) 0.001 $4.85
Chile Food Industry PB Ratio Median Figure of 22 Publicly-Listed Food Companies 0.77x
Chile Market PB Ratio Median Figure of 161 Publicly-Listed Companies 0.81x
SNSE:SALMOCAM PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= SNSE:SALMOCAM Share Price ÷ Book Value per Share (both in USD)

= 4.85 ÷ 3.09

1.57x

* Primary Listing of Salmones Camanchaca.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Salmones Camanchaca is overvalued based on assets compared to the CL Food industry average.
X
Value checks
We assess Salmones Camanchaca's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Food industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Food industry average (and greater than 0)? (1 check)
  5. Salmones Camanchaca has a total score of 4/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

SALMOCAM Future Performance

 How is Salmones Camanchaca expected to perform in the next 1 to 3 years based on estimates from 4 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
13.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Salmones Camanchaca expected to grow at an attractive rate?
  • Salmones Camanchaca's earnings growth is expected to exceed the low risk savings rate of 7.5%.
Growth vs Market Checks
  • Salmones Camanchaca's earnings growth is positive but not above the Chile market average.
  • Salmones Camanchaca's revenue growth is positive but not above the Chile market average.
Annual Growth Rates Comparison
Raw Data
SNSE:SALMOCAM Future Growth Rates Data Sources
Data Point Source Value (per year)
SNSE:SALMOCAM Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts 13.1%
SNSE:SALMOCAM Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 4 Analysts 3.1%
South America Food Industry Earnings Growth Rate Market Cap Weighted Average 8.4%
South America Food Industry Revenue Growth Rate Market Cap Weighted Average 5.1%
Chile Market Earnings Growth Rate Market Cap Weighted Average 14.9%
Chile Market Revenue Growth Rate Market Cap Weighted Average 6.2%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
SNSE:SALMOCAM Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
SNSE:SALMOCAM Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 420 81 1
2022-12-31 367 79 65 3
2021-12-31 350 87 52 3
2020-12-31 372 54 54 3
SNSE:SALMOCAM Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 339 18 42
2019-09-30 294 19 44
2019-06-30 299 18 36
2019-03-31 326 61 32
2018-12-31 329 57 49
2018-09-30 315 52 38
2018-06-30 271 20 45
2018-03-31 232 2 41
2017-12-31 203 37 32
2017-09-30 190 25 33
2017-06-30 209 43 30
2017-03-31 225 65 32

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Salmones Camanchaca's earnings are expected to grow by 13.1% yearly, however this is not considered high growth (20% yearly).
  • Salmones Camanchaca's revenue is expected to grow by 3.1% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
SNSE:SALMOCAM Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below

All data from Salmones Camanchaca Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SNSE:SALMOCAM Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31
2020-12-31
SNSE:SALMOCAM Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 0.64
2019-09-30 0.66
2019-06-30 0.55
2019-03-31 0.48
2018-12-31 0.75
2018-09-30 0.60
2018-06-30 0.57
2018-03-31 0.60
2017-12-31 0.56
2017-09-30 0.70
2017-06-30 1.41
2017-03-31 1.50

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Salmones Camanchaca is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
X
Future performance checks
We assess Salmones Camanchaca's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the South America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the South America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Salmones Camanchaca has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

SALMOCAM Past Performance

  How has Salmones Camanchaca performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Salmones Camanchaca's growth in the last year to its industry (Food).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Salmones Camanchaca has delivered over 20% year on year earnings growth in the past 5 years.
  • Salmones Camanchaca's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Salmones Camanchaca's 1-year earnings growth is negative, it can't be compared to the CL Food industry average.
Earnings and Revenue History
Salmones Camanchaca's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Salmones Camanchaca Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SNSE:SALMOCAM Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 338.96 42.35 18.01
2019-09-30 293.75 43.56 16.42
2019-06-30 298.70 36.37 16.22
2019-03-31 325.62 31.86 17.75
2018-12-31 329.41 49.24 20.65
2018-09-30 314.85 38.47 20.12
2018-06-30 270.59 44.71 19.64
2018-03-31 231.87 40.98 17.69
2017-12-31 203.07 31.72 16.42
2017-09-30 190.18 33.36 15.40
2017-06-30 208.65 30.20 15.47
2017-03-31 224.79 32.23 16.18
2016-12-31 225.55 27.17 15.94
2015-12-31 200.79 -11.09 17.84
2014-12-31 237.95 3.92 15.75

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Salmones Camanchaca has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
  • Salmones Camanchaca used its assets more efficiently than the CL Food industry average last year based on Return on Assets.
  • Salmones Camanchaca has become profitable over the past 3 years. This is considered to be a significant improvement in its use of capital (Return on Capital Employed).
X
Past performance checks
We assess Salmones Camanchaca's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Food industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Salmones Camanchaca has a total score of 4/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

SALMOCAM Health

 How is Salmones Camanchaca's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Salmones Camanchaca's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Salmones Camanchaca is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Salmones Camanchaca's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Salmones Camanchaca's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 2.8x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Salmones Camanchaca Company Filings, last reported 3 months ago.

SNSE:SALMOCAM Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 203.72 99.19 13.92
2019-09-30 207.37 100.68 8.18
2019-06-30 185.70 94.74 9.65
2019-03-31 175.04 51.22 9.54
2018-12-31 183.79 52.33 13.19
2018-09-30 178.28 71.20 18.41
2018-06-30 167.47 83.13 16.29
2018-03-31 170.43 84.15 13.84
2017-12-31 108.68 116.84 0.88
2017-09-30 107.03 107.37 1.45
2017-06-30 24.10 106.20 2.92
2017-03-31 18.25 115.75 1.64
2016-12-31 18.25 115.75 1.64
2015-12-31 -8.94 125.08 1.79
2014-12-31 2.18 136.04 3.53
  • Salmones Camanchaca's level of debt (48.7%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (6318.4% vs 48.7% today).
  • Debt is not well covered by operating cash flow (17.7%, less than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 16.5x coverage).
X
Financial health checks
We assess Salmones Camanchaca's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Salmones Camanchaca has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

SALMOCAM Dividends

 What is Salmones Camanchaca's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
7.42%
Current annual income from Salmones Camanchaca dividends.
If you bought CLP2,000 of Salmones Camanchaca shares you are expected to receive CLP148 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Salmones Camanchaca's pays a higher dividend yield than the bottom 25% of dividend payers in Chile (3.13%).
  • Salmones Camanchaca's dividend is above the markets top 25% of dividend payers in Chile (6.96%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
SNSE:SALMOCAM Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
Chile Food Industry Average Dividend Yield Market Cap Weighted Average of 17 Stocks 5.4%
Chile Market Average Dividend Yield Market Cap Weighted Average of 131 Stocks 5.1%
Chile Minimum Threshold Dividend Yield 10th Percentile 1.1%
Chile Bottom 25% Dividend Yield 25th Percentile 3.1%
Chile Top 25% Dividend Yield 75th Percentile 7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

SNSE:SALMOCAM Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31
2020-12-31
SNSE:SALMOCAM Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-04-08 0.360 4.757
2018-03-21 0.051 0.615

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Whilst dividend payments have been stable, Salmones Camanchaca has been paying a dividend for less than 10 years.
  • Dividend payments have increased, but Salmones Camanchaca only paid a dividend in the past 2 years.
Current Payout to shareholders
What portion of Salmones Camanchaca's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (1.8x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Salmones Camanchaca's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Salmones Camanchaca afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Salmones Camanchaca has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

SALMOCAM Management

 What is the CEO of Salmones Camanchaca's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Manuel Arriagada Ossa
TENURE AS CEO 2 years
CEO Bio

Mr. Manuel Arriagada Ossa is the Chief Executive Officer at Salmones Camanchaca S.A. since April 11, 2018.

CEO Compensation
  • Insufficient data for Manuel to compare compensation growth.
  • Insufficient data for Manuel to establish whether their remuneration is reasonable compared to companies of similar size in .
Management Team Tenure

Average tenure of the Salmones Camanchaca management team in years:

7.2
Average Tenure
  • The average tenure for the Salmones Camanchaca management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Manuel Arriagada Ossa

TITLE
Chief Executive Officer
TENURE
2 yrs

Daniel Ventura

TITLE
Chief Financial Officer
TENURE
8.7 yrs

Marta Rojo

TITLE
Head of IR

Rafael A. Le-Bert Ramírez

TITLE
Head of Legal Affairs
TENURE
7.1 yrs

Igal Neiman Brodsky

TITLE
Head of Marketing
TENURE
8.8 yrs

Pablo Neira Hernández

TITLE
Head of Human Resources
TENURE
7.3 yrs

Juan Carlos Ferrer Echavarri

TITLE
Corporate Business Manager
TENURE
8.3 yrs

Smith Alvaro-Federico Poblete

TITLE
Head of Farming
TENURE
3.5 yrs

Jorge González Vergara

TITLE
Head of Processing
TENURE
3 yrs
Board of Directors Tenure

Average tenure of the Salmones Camanchaca board of directors in years:

2.2
Average Tenure
  • The average tenure for the Salmones Camanchaca board of directors is less than 3 years, this suggests a new board.
Board of Directors

Jorge Fernández García

TITLE
Chairman
TENURE
2 yrs

Ricardo Garcia Holtz

TITLE
Vice Chairman
TENURE
2 yrs

Tore Valderhaug

TITLE
Director
AGE
59
TENURE
2.4 yrs

Hector Luis Felipe Sandoval Precht

TITLE
Director
TENURE
2.4 yrs

Francisco De Borja Cifuentes Correa

TITLE
Director
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CLP) Value (CLP)
04. Jun 19 Sell Ricardo Garcia Holtz Individual 03. Jun 19 03. Jun 19 -8,000 CLP480.82 CLP-3,846,535
X
Management checks
We assess Salmones Camanchaca's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Salmones Camanchaca has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

SALMOCAM News

Simply Wall St News

SALMOCAM Company Info

Description

Salmones Camanchaca S.A. engages in the salmon farming business in Chile. It offers fresh and frozen Atlantic and Pacific salmon in various formats, such as whole, fillet, portion, block, and harasu; and trout. The company operates under the Camanchaca Gourmet and Pier 33 brandsIt also exports its products to the United States, Russia, Brazil, China, Mexico, Japan, Argentina, and internationally. The company was founded in 2009 and is headquartered in Santiago, Chile. Salmones Camanchaca S.A. is a subsidiary of Compañía Pesquera Camanchaca S.A.

Details
Name: Salmones Camanchaca S.A.
SALMOCAM
Exchange: SNSE
Founded: 2009
CLP276,705,000,000
66,000,000
Website: http://www.salmonescamanchaca.cl
Address: Salmones Camanchaca S.A.
Avenida El Golf N° 99,
Piso 10,
Santiago,
7550000,
Chile
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
SNSE SALMOCAM Common Shares Santiago Stock Exchange CL CLP 02. Feb 2018
DB 2SA Common Shares Deutsche Boerse AG DE EUR 02. Feb 2018
OB SALMON Common Shares Oslo Bors NO NOK 02. Feb 2018
BATS-CHIXE SALMOO Common Shares BATS 'Chi-X Europe' GB NOK 02. Feb 2018
Number of employees
Current staff
Staff numbers
1,831
Salmones Camanchaca employees.
Industry
Packaged Foods and Meats
Food, Beverage & Tobacco
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/02 19:55
End of day share price update: 2020/04/01 00:00
Last estimates confirmation: 2020/04/02
Last earnings filing: 2020/02/28
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.